Skip to main content
. 2021 Oct 25;2021:7243052. doi: 10.1155/2021/7243052

Table 5.

Comparison of cardiotoxicity between aconitine and its converted products (mean ± SD).

Compound Dose (mg/kg) VPB incubation period (s) VT incidence (%) Mortality (%)
Aconitine 0.03 97.7 ± 23.7 100 0
16-Epi-pyroaconitine 0.03 0 0
Pyroaconitine 0.03 0 0
0.13 134.1 ± 36.5 80 10

“—” means that no arrhythmias occurred within 30 min after the injection of the experimental compounds.